TBPH

TBPH Net Income Growth

312.92%TTM

Period ending:

TBPH TTM Net Income YoY %%
TBPH TTM Net Income YoY %1083.39%-234.22%
2014-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

TBPH net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 49 observations from Jun 30, 2014 to Jun 30, 2026.

Theravance Biopharma Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
312.923%
296.3571%
287.6972%
159.3996%
128.5436%
-30.2978%
-2.2195%
13.3999%
-105.2563%
-105.1107%
-106.3285%
-106.7075%
955.8776%
701.2574%
537.3211%
476.5997%
61.5844%
46.9519%
28.2684%
20.8153%
2.1543%
-11.2239%
-17.5771%
-29.0244%
-21.591%
-10.7216%
-9.7117%
12.3781%
14.5038%
21.7959%
24.4849%
5.0994%
-11.5088%
-33.3594%
-49.6861%
-58.0698%
-28.309%
-17.5625%
-4.6384%
16.6276%
13.1017%
17.1308%
23.1275%
6.9679%
-2.6997%
-19.2073%
-51.6713%
-53.3447%
-53.0372%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All TBPH financial metrics · TBPH stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.